Acyclovir vs Ipilimumab

## Acyclovir vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Acyclovir** and **Ipilimumab**.

## Mechanism of Action

**Acyclovir**: Guanosine analogue inhibiting viral DNA polymerase.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Acyclovir — 2.5-3.3 hours; Ipilimumab — 14.7 days.

## Chemical Properties

**Molecular Formula**: Acyclovir — C8H11N5O3; Ipilimumab — N/A.

**Molecular Weight**: Acyclovir — 225.2050 g/mol; Ipilimumab — N/A.

**Type**: Acyclovir — Small molecule; Ipilimumab — Antibody.